Chandan Kumar Singh
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Chandan Kumar Singh has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Pran Kishore Deb
Department of Pharmaceutical Sciences and Technology, Birla Institute of Technology (BIT), Mesra, Ranchi 835215, Jharkhand, India
3 shared publications Anroop B. Nair
Department of Pharmaceutical Sciences, College of Clinical Pharmacy, King Faisal University, Al-Ahsa , Saudi Arabia
1 shared publication- Jagadeesh Prasad Dasappa
Department of Chemistry, Mangalore University, Mangalagangotri-574199, Karnataka State, India
1 shared publication - K.B. Vilas Gowda
Department of Biotechnology and Bioinformatics, School of Life Sciences, JSS Academy of Higher Education & Research, Mysuru 570015, India
1 shared publication - Katharigatta Narayanaswamy Venugopala
Department of Pharmaceutical Sciences, College of Clinical Pharmacy, King Faisal University, Al-Ahsa 31982, Saudi Arabia
1 shared publication - Monika Dwivedi
Department of Pharmaceutical Sciences and Technology, Birla Institute of Technology, Ranchi, India
1 shared publication
Latest Publications
- 21 July 2026
- Published by Elsevier in Bioorganic Chemistry
- Vol. 181, 110263
Oxadiazole and hydrazone derivatives of benzimidazothiazine as potential antifungal and anti-tubercular agents
- 21 July 2026
- Published by Elsevier in Bioorganic Chemistry
- Vol. 181, 110263
Oxadiazole and hydrazone derivatives of benzimidazothiazine as potential antifungal and anti-tubercular agents
- 2 April 2026
- Published by Springer Nature in AAPS PharmSciTech
- Vol. 27 (3) , 168
Polymer Drug Conjugate: A Revolution in Drug Delivery
Polymer-drug conjugates (PDCs) represent a remarkable advancement in modern medicine, leveraging the physicochemical properties of polymers to enhance the
- 2 April 2026
- Published by Springer Nature in AAPS PharmSciTech
- Vol. 27 (3) , 168
Polymer Drug Conjugate: A Revolution in Drug Delivery
Polymer-drug conjugates (PDCs) represent a remarkable advancement in modern medicine, leveraging the physicochemical properties of polymers to enhance the
- 4 February 2026
- Published by Springer Nature in AAPS PharmSciTech
- Vol. 27 (2) , 93
Recent Trends in the Development and Clinical Translation of Polymer-based Targeted Therapeutic Nanoparticle
Polymeric nanoparticles are a state-of-the-art innovation in nanomedicine, offering site-specific drug delivery, an improved pharmacokinetic profile, and a
- 4 February 2026
- Published by Springer Nature in AAPS PharmSciTech
- Vol. 27 (2) , 93
Recent Trends in the Development and Clinical Translation of Polymer-based Targeted Therapeutic Nanoparticle
Polymeric nanoparticles are a state-of-the-art innovation in nanomedicine, offering site-specific drug delivery, an improved pharmacokinetic profile, and a